179 related articles for article (PubMed ID: 33637823)
1. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
Balz K; Kaushik A; Chen M; Cemic F; Heger V; Renz H; Nadeau K; Skevaki C
Sci Rep; 2021 Feb; 11(1):4792. PubMed ID: 33637823
[TBL] [Abstract][Full Text] [Related]
2. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
Balz K; Chen M; Kaushik A; Cemic F; Heger V; Renz H; Nadeau K; Skevaki C
Res Sq; 2020 Oct; ():. PubMed ID: 33052330
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive MHC class I T cell epitopes may dictate heterologous immune responses between respiratory viruses and food allergens.
Balz K; Kaushik A; Cemic F; Sampath V; Heger V; Renz H; Nadeau K; Skevaki C
Sci Rep; 2023 Sep; 13(1):14874. PubMed ID: 37684288
[TBL] [Abstract][Full Text] [Related]
4. Immunoinformatic based identification of cytotoxic T lymphocyte epitopes from the Indian isolate of SARS-CoV-2.
Mulpuru V; Mishra N
Sci Rep; 2021 Feb; 11(1):4516. PubMed ID: 33633155
[TBL] [Abstract][Full Text] [Related]
5. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
Guo E; Guo H
PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nelde A; Bilich T; Heitmann JS; Maringer Y; Salih HR; Roerden M; Lübke M; Bauer J; Rieth J; Wacker M; Peter A; Hörber S; Traenkle B; Kaiser PD; Rothbauer U; Becker M; Junker D; Krause G; Strengert M; Schneiderhan-Marra N; Templin MF; Joos TO; Kowalewski DJ; Stos-Zweifel V; Fehr M; Rabsteyn A; Mirakaj V; Karbach J; Jäger E; Graf M; Gruber LC; Rachfalski D; Preuß B; Hagelstein I; Märklin M; Bakchoul T; Gouttefangeas C; Kohlbacher O; Klein R; Stevanović S; Rammensee HG; Walz JS
Nat Immunol; 2021 Jan; 22(1):74-85. PubMed ID: 32999467
[TBL] [Abstract][Full Text] [Related]
8. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
[TBL] [Abstract][Full Text] [Related]
10. Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria.
Eggenhuizen PJ; Ng BH; Chang J; Cheong RMY; Yellapragada A; Wong WY; Ting YT; Monk JA; Gan PY; Holdsworth SR; Ooi JD
Front Immunol; 2022; 13():821595. PubMed ID: 35154139
[TBL] [Abstract][Full Text] [Related]
11. Influenza-derived peptides cross-react with allergens and provide asthma protection.
Skevaki C; Hudemann C; Matrosovich M; Möbs C; Paul S; Wachtendorf A; Alashkar Alhamwe B; Potaczek DP; Hagner S; Gemsa D; Garn H; Sette A; Renz H
J Allergy Clin Immunol; 2018 Sep; 142(3):804-814. PubMed ID: 29132960
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
Front Immunol; 2021; 12():812176. PubMed ID: 35095907
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
Front Immunol; 2020; 11():2008. PubMed ID: 33013857
[TBL] [Abstract][Full Text] [Related]
14. Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.
Piadel K; Haybatollahi A; Dalgleish AG; Smith PL
J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35014605
[TBL] [Abstract][Full Text] [Related]
15. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
16. A bioinformatic analysis: Previous allergen exposure may support anti- SARS-CoV-2 immune response.
Karagöz IK; Kaya M; Rückert R; Bozman N; Kaya V; Bayram H; Yıldırım M
Comput Biol Chem; 2023 Dec; 107():107961. PubMed ID: 37788543
[TBL] [Abstract][Full Text] [Related]
17. CRESSP: a comprehensive pipeline for prediction of immunopathogenic SARS-CoV-2 epitopes using structural properties of proteins.
An H; Eun M; Yi J; Park J
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35226074
[TBL] [Abstract][Full Text] [Related]
18. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
Jain N; Shankar U; Majee P; Kumar A
Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
Kushwaha SK; Kesarwani V; Choudhury S; Gandhi S; Sharma S
Genomics; 2020 Nov; 112(6):5044-5054. PubMed ID: 32920121
[TBL] [Abstract][Full Text] [Related]
20. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses.
Tan CCS; Owen CJ; Tham CYL; Bertoletti A; van Dorp L; Balloux F
Infect Genet Evol; 2021 Nov; 95():105075. PubMed ID: 34509646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
